Arginase 2 and nitric oxide synthase: Pathways associated with the pathogenesis of thyroid tumors.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Free Radical Biology & Medicine

• Publication date

  2010-09-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.freeradbiomed.2010.06.006PMID 20542107
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Intracellular expression of reactive oxygen species-generating NADPH oxidase NOX4 in normal and cancer thyroid tissues.

  2010cited by this paper
• Endothelial NOS, estrogen receptor beta, and HIFs cooperate in the activation of a prognostic transcriptional pattern in aggressive human prostate cancer.

  2009cited by this paper
• Down‐regulation of NR4A1 in follicular thyroid carcinomas is restored following lithium treatment

  2009cited by this paper
• The Akt1-eNOS Axis Illustrates the Specificity of Kinase-Substrate Relationships in Vivo

  2009influential reference
• Nitric oxide delivery to cancer: why and how?

  2009cited by this paper
• Nitric oxide: cancer target or anticancer agent?

  2009cited by this paper
• Transcriptome-wide measurement of mRNA polyadenylation state.

  2009cited by this paper
• Negative correlation between thyroperoxidase and dual oxidase H2O2-generating activities in thyroid nodular lesions.

  2008cited by this paper
• Tumour maintenance is mediated by eNOS

  2008cited by this paper
• Effect of arginase II on L-arginine depletion and cell growth in murine cell lines of renal cell carcinoma

  2008cited by this paper
• Disruption of arginase II alters prostate tumor formation in TRAMP mice

  2008cited by this paper
• Nitric oxide, apoptosis and macrophage polarization during tumor progression.

  2008influential reference
• Re-expression of ABI3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion.

  2008cited by this paper
• Arginase 2 is expressed by human lung cancer, but it neither induces immune suppression, nor affects disease progression

  2008cited by this paper
• Nitric Oxide/cGMP Signaling Inhibits TSH-Stimulated Iodide Uptake and Expression of Thyroid Peroxidase and Thyroglobulin mRNA in FRTL-5 Thyroid Cells

  2007cited by this paper
• Molecular profiling of matched samples identifies biomarkers of papillary thyroid carcinoma lymph node metastasis.

  2007cited by this paper
• The role of nitric oxide in tumour progression

  2006influential reference
• Diagnosis of Suspicious Thyroid Nodules Using Four Protein Biomarkers

  2006cited by this paper
• A new model for translational regulation of specific mRNAs.

  2006cited by this paper
• Gene Expression Profiles Reveal that DCN, DIO1, and DIO2 Are Underexpressed in Benign and Malignant Thyroid Tumors

  2005cited by this paper
• NOX enzymes and the biology of reactive oxygen

  2004cited by this paper
• Evaluation of the nitric oxide production in rat renal artery smooth muscle cells culture exposed to radiocontrast agents.

  2004cited by this paper
• A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.

  2004cited by this paper
• Arginases I and II: do their functions overlap?

  2004cited by this paper
• Elevated Serum Arginase Activity Levels in Patients with Breast Cancer

  2003cited by this paper
• Is inducible nitric oxide synthase a target for chemoprevention?

  2003cited by this paper
• Mitochondrial nitric oxide synthase is not eNOS, nNOS or iNOS.

  2003cited by this paper
• What can digital transcript profiling reveal about human cancers?

  2003cited by this paper
• Arginase in patients with breast cancer.

  2003cited by this paper
• Arginase in patients with breast cancer.

  2003cited by this paper
• Nitrotyrosine, inducible nitric oxide synthase (iNOS), and endothelial nitric oxide synthase (eNOS) are increased in thyroid tumors from children and adolescents

  2002cited by this paper
• Regulatory role of arginase I and II in nitric oxide, polyamine, and proline syntheses in endothelial cells.

  2001cited by this paper
• Antiapoptotic role of endogenous nitric oxide in human melanoma cells.

  2001cited by this paper
• Evidence of a functional role for the cyclin-dependent kinase-inhibitor p21WAF1/CIP1/MDA6 in promoting differentiation and preventing mitochondrial dysfunction and apoptosis induced by sodium butyrate in human myelomonocytic leukemia cells (U937).

  2001cited by this paper
• Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells.

  2000influential reference
• Expression of nitric oxide synthase III in human thyroid follicular cells: evidence for increased expression in hyperthyroidism.

  1997cited by this paper
• p21(Waf1/Cip1) protects against p53-mediated apoptosis of human melanoma cells.

  1997cited by this paper
• The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells

  1996cited by this paper
• H-40, an antigen controlled by an Igh linked gene and recognized by cytotoxic T lymphocytes. I. Genetic analysis of H-40 and distribution of its product on B cell tumors

  1984cited by this paper
• Early diagnosis of myocardial infarction by arginase activity determination.

  1975cited by this paper
• Photometric estimation of proline and ornithine.

  1952cited by this paper

• PLB1 enhances adhesion and invasion of Trichosporon asahii to lung epithelial cells: insights into the mechanisms of Cav1/JAK/STAT3-induced arginine metabolism

  2026cites this paper
• Arginase 2 Promotes Colorectal Cancer Metastasis via PI3K/AKT Pathway Activation and Regulates Tumor Immune Infiltration

  2026cites this paper
• WTAP-mediated m6A modification of ARG2 mRNA Inhibits Its expression and drives prostate cancer malignant progression.

  2025cites this paper
• Metabolic Adaptations in Cancer Progression: Optimization Strategies and Therapeutic Targets

  2025cites this paper
• Targeting the glutamine-arginine-proline metabolism axis in cancer

  2024cites this paper
• Pathophysiology of Arginases in Cancer and Efforts in Their Pharmacological Inhibition

  2024cites this paper
• Amino acid metabolism in health and disease

  2023cites this paper
• Nitric oxide, thyroglobulin, and calcitonin: unraveling the nature of thyroid nodules

  2023influential citation
• Nitric oxide and thyroid carcinoma: A review

  2023cites this paper
• Regulated Arginine Metabolism in Immunopathogenesis of a Wide Range of Diseases: Is There a Way to Pass between Scylla and Charybdis?

  2023cites this paper
• Mechanisms of Antiproliferative Action of Streptococcal Arginine Deiminase Against Jurkat Lymphoblastic Leukemia Cells

  2023cites this paper
• Integrated network pharmacology and experimental validation to explore the mechanisms underlying naringenin treatment of chronic wounds

  2023cites this paper
• Mechanisms of Antiproliferative Effect of Streptococcal Arginine Deiminase on Jurkat Lymphoblastic Leukemia Cells

  2023cites this paper
• Identification and Validation of a Prognostic Model Based on Three MVI-Related Genes in Hepatocellular Carcinoma

  2022cites this paper
• Arginase: An emerging and promising therapeutic target for cancer treatment.

  2022cites this paper
• Out of the cycle: Impact of cell cycle aberrations on cancer metabolism and metastasis

  2022cites this paper
• The uniqueness and superiority of energy utilization in yaks compared with cattle in the highlands: A review

  2022cites this paper
• NKX2-1 re-expression induces cell death through apoptosis and necrosis in dedifferentiated thyroid carcinoma cells

  2021cites this paper
• Arginase 2 as a metabolic immune checkpoint in anti-tumor immunity

  2019cites this paper
• Yin and Yang of Pluripotency: Results of Analysis of Genes Overexpressed In Tumor-Initiating Cells of Krebs-2 Ascites Carcinoma

  2019cites this paper
• Downregulation of ARG 2 inhibits growth of colorectal cancer cells and increases expression of the CD 3 ζ chain in co-cultured T-cells

  2019cites this paper
• S-nitrosothiols and H2S donors: Potential chemo-therapeutic agents in cancer

  2019cites this paper
• Cancer Stem Cells: Emergent Nature of Tumor Emergency

  2018cites this paper
• Mechanistic Investigations Into the Developmental Toxicity of Nitrated and Heterocyclic PAHs

  2017cites this paper
• Cancer Genetics at a Glance: The Comprehensive Insights

  2017cites this paper
• Nitric oxide-repressed Forkhead factor FoxE1 expression is involved in the inhibition of TSH-induced thyroid peroxidase levels.

  2016cites this paper
• Hepatic Arginase - Nitric oxide imbalance: Impact of carcinogenesis and therapeutic effect of sodium channel blockage in an in vivo rat model

  2016cites this paper
• Sunitinib depletes myeloid-derived suppressor cells and synergizes with a cancer vaccine to enhance antigen-specific immune responses and tumor eradication

  2015cites this paper
• Nitric oxide: Protein tyrosine phosphorylation and protein S-nitrosylation in cancer

  2015cites this paper
• Forced LIGHT expression in prostate tumors overcomes Treg mediated immunosuppression and synergizes with a prostate tumor therapeutic vaccine by recruiting effector T lymphocytes

  2015cites this paper
• miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma

  2014cites this paper
• Arginase in retinopathy.

  2013cites this paper
• Chapter 34 – Arginase, Nitric Oxide Synthase, and Novel Inhibitors of L-arginine Metabolism in Immune Modulation

  2013cites this paper
• Prognostic value of arginase‐II expression and regulatory T‐cell infiltration in head and neck squamous cell carcinoma

  2013cites this paper
• A Role for Nitric Oxide and for Nitric Oxide Synthases in Tumor Biology

  2012cites this paper
• Interferon-Gamma-Induced Nitric Oxide Inhibits the Proliferation of Murine Renal Cell Carcinoma Cells

  2012cites this paper
• Retinoblastoma treatment: impact of the glycolytic inhibitor 2-deoxy-d-glucose on molecular genomics expression in LHBETATAG retinal tumors

  2012cites this paper
• Apoptosis, Free Radicals and Antioxidant Defense in Antitumor Therapy

  2012cites this paper
• The yak genome and adaptation to life at high altitude

  2012cites this paper
• Analyse und Modulation des Tumormetabolismus in humanen Tumorzelllinien und Tumorgeweben

  2012cites this paper
• Amino acids in human nutrition and health.

  2011cites this paper
• Immunosuppression associée à l’enzyme interleukine-4 induced gene 1 (IL4I1) : régulation de l’expression dans les cellules humaines et rôle dans l’échappement tumoral à la réponse immune dans un modèle murin

  2011cites this paper
• Cross Sectional Evaluation of the Relationship Between Nitrates and Cancer Diagnoses

  2008cites this paper